Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBeth Israel Deaconess Medical Center

About this trial

The aim of the study is to assess whether perioperative use of high-flow nasal oxygen (HFNO) during the period from induction of anesthesia until discharge from the post-anesthesia care unit in patients undergoing robotic-assisted surgery reduces perioperative oxygen desaturation and postoperative pulmonary complications.

Eligibility criteria

Qualifiers

Age >= 18

Undergoing non-emergent, non-cardiac, intra-abdominal, intra-thoracic or pelvic robot-assisted surgery with an expected duration of at least 2 hours under general anesthesia with planned extubation at the end of the procedure

Disqualifiers

Known pregnancy

Preoperative intubation or tracheostomy

Anatomical or clinical conditions precluding the use of high-flow nasal oxygen (severe midface trauma, recent nasal surgery, severe nasal septum deviation, severe nasal deformation)

Contraindications to electrical impedance tomography (EIT), including inability to place the EIT belt or presence of active implantable electronic devices (e.g., pacemaker or implantable cardioverter-defibrillator)

Trial design

Treatments tested in this trial

  • High flow nasal oxygen

Treatment groups

190 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Beth Israel Deaconess Medical Center

Lead sponsor

Fisher and Paykel Healthcare

Collaborator